Assessment of community pharmacists’ knowledge about utilization, safety, and interactions of commonly prescribed anticoagulants: A report from North West of Iran Community pharmacists’ knowledge about anticoagulants
International Pharmacy Acta,
Page e1: 1-5
Anticoagulants are used to treat different thrombotic conditions, and patients should be educated on administration, safety, and adverse reactions associated with their medication to achieve the optimum therapeutic effect. Pharmacists are an essential part of providing pharmaceutical care and a reliable source of information for patients; therefore, their knowledge of medications must be up-to-date. This study aimed to assess Urmia’s community pharmacists’ knowledge about the utilization, safety, and interactions of commonly prescribed anticoagulants.
This questionnaire-based cross-sectional study was conducted from September 1st, 2020, to February 31st, 2021, in Urmia, Iran. A 35-item questionnaire was designed based on previous studies and researchers’ experience. The questionnaire was validated, and its final version was presented to randomly selected community pharmacists in Urmia. Filled-out forms were collected and analyzed in the context of three main areas of safety, adverse reactions, and administration.
Ninety-five participants filled out the questionnaire, for whom a mean score of 16.53±4.56 was calculated. Out of 95 pharmacists, only 30 scored ≥50% correct answers. No significant correlation was observed between age, years of employment, and pharmacists' competency in correctly answering the questions (p-value>0.05). The participants' overall knowledge was more reliable for warfarin than for enoxaparin and DOACs, with a p-value<0.001.
The results of this study suggest a lack of sufficient knowledge among Urmia’s community pharmacists concerning commonly prescribed anticoagulants. This puts patients at risk for therapy complications and should be addressed accordingly.
- community pharmacist
How to Cite
Kim JH, Lim K-M, Gwak HS. New anticoagulants for the prevention and treatment of venous thromboembolism. Biomolecules & therapeutics. 2017;25(5):461.
Lippi G, Mattiuzzi C, Cervellin G, Favaloro EJ. Direct oral anticoagulants: analysis of worldwide use and popularity using Google Trends. Ann Transl Med. 2017;5(16):322.
Mazzolai L, Aboyans V, Ageno W, Agnelli G, Alatri A, Bauersachs R, et al. Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function. Eur Heart J. 2018;39(47):4208-18.
Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2):e44S-e88S.
QuarterWatch (2016 Annual Report) [Last accessed on 2018 Oct 6]. Part II: Oral Anticoagulants—The Nation’s Top Risk of AcuteInjury from Drugs | Institute for Safe Medication Practices.
Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018;39(16):1330-93.
Witt DM, Clark NP, Kaatz S, Schnurr T, Ansell JE. Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism. J Thromb Thrombolysis. 2016;41(1):187-205.
Entezari-Maleki T, Dousti S, Hamishehkar H, Gholami K. A systematic review on comparing 2 common models for management of warfarin therapy; pharmacist-led service versus usual medical care. J Clin Pharmacol. 2016;56(1):24-38.
Tschol N, Lai D, Tilley JA, Wong H, Brown GR. Comparison of physician-and pharmacist-managed warfarin sodium treatment in open heart surgery patients. The Canadian journal of cardiology. 2003;19(12):1413-7.
Fahimi F, Sharif-Kashani B, Hossein-Ahmadi Z, Salamzadeh J, Namdar R, Mousavi S, et al. The first pharmacist-based warfarin-monitoring service in Iran. Journal of Pharmaceutical Health Services Research. 2011;2(1):59-62.
Elewa H, Jalali F, Khudair N, Hassaballah N, Abdelsamad O, Mohammed S. Evaluation of pharmacist‐based compared to doctor‐based anticoagulation management in Q atar. Journal of evaluation in clinical practice. 2016;22(3):433-8.
Fuentes AV, Pineda MD, Venkata KCN. Comprehension of Top 200 Prescribed Drugs in the US as a Resource for Pharmacy Teaching, Training and Practice. Pharmacy (Basel). 2018;6(2).
Enoxaparin. In: Lexi-drugs online [database on the Internet]. Hudson (OH): Lexicomp, Inc.; 2021[updated 12 Sep 2020; cited 9 Apr 2020]. Available from: http://online.lexi.com. Subscription required to view. [Internet]. 2020.
Rivaroxaban. In: Lexi-drugs online [database on the Internet]. Hudson (OH): Lexicomp, Inc.; 2021[updated 12 Sep 2020; cited 9 Apr 2020]. Available from: http://online.lexi.com. Subscription required to view.
Cronbach LJ, Shavelson RJ. My current thoughts on coefficient alpha and successor procedures. Educational and psychological measurement. 2004;64(3):391-418.
Ghaibi S, Ipema H, Gabay M. ASHP guidelines on the pharmacist’s role in providing drug information. American Journal of Health-System Pharmacy. 2015;72(7):573-7.
Burns A. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). Journal of the American Pharmacists Association. 2008;48(3):341-53.
Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149(2):315-52.
Lip GY, Banerjee A, Boriani G, en Chiang C, Fargo R, Freedman B, et al. Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report. Chest. 2018;154(5):1121-201.
Hawes EM. Patient Education on Oral Anticoagulation. Pharmacy (Basel). 2018;6(2).
Urick BY, Meggs EV. Towards a greater professional standing: evolution of pharmacy practice and education, 1920–2020. Pharmacy. 2019;7(3):98.
El-Bardissy A, Elewa H, Khalil A, Mekkawi W, Mohammed S, Kassem M, et al. Assessing Pharmacists Knowledge and Attitude Toward the Direct Oral Anticoagulants in Qatar. Clin Appl Thromb Hemost. 2020;26:1076029620933946.
Mohamed AA, Alnewais ME, Ibrahim YA, Zaitoun MF. Pharmacists' warfarin therapy knowledge and counseling practices in the Eastern Province, Saudi Arabia: A cross-sectional study. J Pharm Bioallied Sci. 2020;12(3):289-94.
Papastergiou J, Kheir N, Ladova K, Rydant S, De Rango F, Antoniou S, et al. Pharmacists' confidence when providing pharmaceutical care on anticoagulants, a multinational survey. Int J Clin Pharm. 2017;39(6):1282-90.
Bates SM, Rajasekhar A, Middeldorp S, McLintock C, Rodger MA, James AH, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018;2(22):3317-59.
Mueck W, Stampfuss J, Kubitza D, Becka M. Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban. Clin Pharmacokinet. 2014;53(1):1-16.
Raynor D, Silcock J, Knapp P, Edmondson H. How do patients use medicine information leaflets in the UK? International Journal of Pharmacy Practice. 2007;15(3):209-18.
- Abstract Viewed: 41 times
- IPA-2023-Vol6-e1 Downloaded: 666 times